What the board needs to hear from investor relations

Consider a hypothetical manufacturer planning a new facility. Management describes strong demand and attractive margins. An investor asks whether the customers supporting that demand will place orders at the prices assumed once the facility opens. A summary that reads ‘questions on capacity ramp-up’ is accurate at a superficial level. It removes the tension between volume and price that makes the question worth asking.

The useful board account preserves both positions. Management believes customer discussions support its assumptions. The investor sees a risk that demand will materialise only at a lower margin. Neither position is established by confidence alone. Directors need to understand the supporting evidence, its limitations and how much the investment case depends on the disputed assumption.

IR should therefore distinguish three things in its reporting: what was said, what IR infers from it and what management proposes to do. An attributed observation should not quietly become a consensus view. An interpretation should not acquire the status of a fact through repetition. Clear distinctions make difficult information easier to examine fairly.

An investor may lack information that the company has already made public but explained poorly. They may understand the strategy and reject an assumption within it. They may accept the economics yet doubt management’s ability to deliver. Each deserves a different response. More presentation pages will not resolve an execution problem; changing a sound investment decision will not remedy a confusing explanation.

The diagnosis should also distinguish a request from a concern. A request for more detailed disclosure may be a practical way of testing a wider issue, such as whether growth is concentrated in less profitable customers. Management can examine the underlying issue even where the precise disclosure requested would be commercially inappropriate.

Frequency helps establish the breadth of a concern, but it cannot establish its merit. Ten investors repeating the same market assumption may offer less new information than one investor who identifies an inconsistency between the operating plan and the cash forecast. IR should make both the reach and the reasoning visible. The board can then decide what weight each deserves.

The G20/OECD Principles of Corporate Governance call for clear board and management responsibilities for disclosure and communication. They recognise direct reporting by an investor relations officer to the board as good practice in some jurisdictions.¹ The practical question for each company is whether its chosen arrangements allow a significant concern to reach directors when its interpretation is contested.

Administrative reporting to the CFO can support financial accuracy and coordination. Access to the chair or an appropriate independent director can serve a different purpose: ensuring that unresolved concerns receive a hearing. These arrangements can coexist. A mandate should identify the route, the matters requiring escalation and the circumstances in which IR can request a confidential discussion.

Management should normally see the issue and have an opportunity to provide its response. The board should receive the disagreement intact, with competing explanations presented on their merits. This is especially important when the concern relates to a commitment the leadership team has publicly defended. A process that relies entirely on the agreement of those whose judgement is being questioned is vulnerable at precisely that moment.

Giving investor feedback more board attention carries a risk: oversight could become a running referendum on strategy. Shareholders have different objectives, information and time horizons. Some may prefer a near-term distribution to an investment that directors believe serves the company well. An influential investor’s dissatisfaction is not, by itself, evidence of a flawed decision.

The safeguard is analytical discipline. Ask which assumption the objection challenges, whether the evidence is credible and what would change the board’s conclusion. Directors may decide to continue an unpopular programme. Their confidence should rest on an examined case, including its weaknesses. An assertion that the market has misunderstood the company cannot supply that basis.

IR’s internal access also needs clear boundaries. It should operate within established disclosure controls, confidentiality requirements and decision rights. Bringing a concern to directors does not authorise IR to make commitments to investors. The board remains responsible for judgement; management remains responsible for execution. IR improves the information connecting those responsibilities.

A discussion is incomplete until somebody knows what happens next. The board may request an investigation, commission a clearer explanation, change a decision or accept a risk. It may decide that no action is warranted. In each case, the record should identify the reasoning, an accountable owner where action is required and the evidence or event that would justify revisiting the conclusion.

This creates a useful test over time. If the same concern returns after several reporting periods, establish whether the company failed to explain its response, failed to execute it or discovered that the original diagnosis was wrong. Without that continuity, management can answer each occurrence competently while never resolving the underlying issue.

The appraisal of IR should reflect this contribution. Independent director input can help assess whether uncomfortable evidence arrived intact, management’s response was represented fairly and unresolved matters remained visible. Meeting volumes and favourable share-price movements cannot answer those questions. A chair can begin by asking IR to bring one significant objection management disputes, together with the strongest evidence on each side and a proposal for resolving the difference.